Methodology

All entries for: Evolyra Therapeutics

February 27, 2026

Evolyra Therapeutics

Orphan Drug Designation

treatment of limb-girdle muscular dystrophy type 2C/R5 (LGMD2C/R5)

Disease Area: Rare Disease